Literature DB >> 21420206

N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.

Gema C González-Muñoz1, Mariana P Arce, Beatriz López, Concepción Pérez, Alejandro Romero, Laura del Barrio, María Dolores Martín-de-Saavedra, Javier Egea, Rafael León, Mercedes Villarroya, Manuela G López, Antonio G García, Santiago Conde, María Isabel Rodríguez-Franco.   

Abstract

We have previously reported the multifunctional profile of N-(3-chloro-10H-phenothiazin-10-yl)-3-(dimethylamino)propanamide (1) as an effective neuroprotectant and selective butyrylcholinesterase inhibitor. In this paper, we have developed a series of N-acylaminophenothiazines obtained from our compound library or newly synthesised. At micro- and sub-micromolar concentrations, these compounds selectively inhibited butyrylcholinesterase (BuChE), protected neurons against damage caused by both exogenous and mitochondrial free radicals, showed low toxicity, and could penetrate into the CNS. In addition, N-(3-chloro-10H-phenothiazin-10-yl)-2-(pyrrolidin-1-yl)acetamide (11) modulated the cytosolic calcium concentration and protected human neuroblastoma cells against several toxics, such as calcium overload induced by an L-type Ca2+-channel agonist, tau-hyperphosphorylation induced by okadaic acid and Aβ peptide.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420206     DOI: 10.1016/j.ejmech.2011.03.003

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  13 in total

1.  Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome.

Authors:  Alicia Mansilla; Antonio Chaves-Sanjuan; Nuria E Campillo; Ourania Semelidou; Loreto Martínez-González; Lourdes Infantes; Juana María González-Rubio; Carmen Gil; Santiago Conde; Efthimios M C Skoulakis; Alberto Ferrús; Ana Martínez; María José Sánchez-Barrena
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-24       Impact factor: 11.205

2.  Synthesis and in vitro evaluation of α-synuclein ligands.

Authors:  Lihai Yu; Jinquan Cui; Prashanth K Padakanti; Laura Engel; Devika P Bagchi; Paul T Kotzbauer; Zhude Tu
Journal:  Bioorg Med Chem       Date:  2012-06-19       Impact factor: 3.641

3.  PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice.

Authors:  Silvia Lorrio; Alejandro Romero; Laura González-Lafuente; Rocío Lajarín-Cuesta; Francisco J Martínez-Sanz; Martín Estrada; Abdelouahid Samadi; Jose Marco-Contelles; María Isabel Rodríguez-Franco; Mercedes Villarroya; Manuela G López; Cristóbal de los Ríos
Journal:  ACS Chem Neurosci       Date:  2013-06-13       Impact factor: 4.418

4.  Benzothiazepine CGP37157 and its isosteric 2'-methyl analogue provide neuroprotection and block cell calcium entry.

Authors:  Laura González-Lafuente; Javier Egea; Rafael León; Francisco J Martínez-Sanz; Leticia Monjas; Concepción Perez; Cristina Merino; Antonio M García-De Diego; María I Rodríguez-Franco; Antonio G García; Mercedes Villarroya; Manuela G López; Cristóbal de Los Ríos
Journal:  ACS Chem Neurosci       Date:  2012-03-26       Impact factor: 4.418

Review 5.  Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.

Authors:  Natalia Guzior; Anna Wieckowska; Dawid Panek; Barbara Malawska
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

6.  Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease.

Authors:  Isabel Gameiro; Patrycja Michalska; Giammarco Tenti; Ángel Cores; Izaskun Buendia; Ana I Rojo; Nikolaos D Georgakopoulos; Jesús M Hernández-Guijo; María Teresa Ramos; Geoffrey Wells; Manuela G López; Antonio Cuadrado; J Carlos Menéndez; Rafael León
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

7.  Neurite Outgrowth and Neuroprotective Effects of Quercetin from Caesalpinia mimosoides Lamk. on Cultured P19-Derived Neurons.

Authors:  Napat Tangsaengvit; Worawan Kitphati; Sarin Tadtong; Nuntavan Bunyapraphatsara; Veena Nukoolkarn
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-11       Impact factor: 2.629

8.  Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.

Authors:  Angel Agis-Torres; Monica Sölhuber; Maria Fernandez; J M Sanchez-Montero
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363

9.  New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease.

Authors:  Kamila Czarnecka; Małgorzata Girek; Przemysław Wójtowicz; Paweł Kręcisz; Robert Skibiński; Jakub Jończyk; Kamil Łątka; Marek Bajda; Anna Walczak; Grzegorz Galita; Jacek Kabziński; Ireneusz Majsterek; Piotr Szymczyk; Paweł Szymański
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

10.  Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease.

Authors:  Wenhao Wu; Xintong Liang; Guoquan Xie; Langdi Chen; Weixiong Liu; Guolin Luo; Peiquan Zhang; Lihong Yu; Xuehua Zheng; Hong Ji; Chao Zhang; Wei Yi
Journal:  Molecules       Date:  2018-10-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.